ArticleOncotarget2015

JAK2 inhibitor TG101348 overcomes erlotinib-resistance in non-small cell lung carcinoma cells with mutated EGF receptor.

Fu-quan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.